Kenyadah M Gamble

Kenyadah M. Gamble supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing critical procurement activities that enable public health surveillance, laboratory diagnostics, and biomedical research operations. Responsible for executing complex acquisition strategies, Gamble focuses on securing advanced technical solutions that enhance infectious disease detection, clinical data systems, and laboratory infrastructure. Their work directly supports CDC’s mission to safeguard national health through rapid, science-driven responses, with a primary emphasis on high-precision equipment maintenance and specialized software solutions essential to public health data integrity and operational readiness. Gamble maintains consistent working relationships with key contractors including General Dynamics Information Technology, GlaxoSmithKline, New York City Health & Hospitals Corp, MRIGLOBAL, and Cepheid. These partnerships reflect a strategic alignment with industry leaders capable of delivering high-compliance, high-reliability services in diagnostics, laboratory automation, and public health informatics. The contracting approach emphasizes performance-based outcomes, technical validation, and long-term service support, ensuring continuity in mission-critical health infrastructure. Gamble’s procurement portfolio reflects a strong preference for full and open competition, with 100% of awards issued without set-aside designations. This pattern indicates a focus on technical capability and operational urgency over socioeconomic classifications, prioritizing mission-critical delivery over socioeconomically targeted contracting mechanisms. While small business participation is not formally prioritized in award structure, vendor selection remains rooted in proven technical proficiency and compliance with federal health security standards. The primary NAICS focus areas are 811210 (Electronic and Precision Equipment Repair and Maintenance) and 513210 (Software Publishers), underscoring deep expertise in maintaining laboratory instrumentation and deploying public health data analytics platforms. Gamble specializes in procuring calibrated diagnostic devices, biosafety-compliant IT systems, and real-time surveillance software critical to CDC’s epidemiological response capabilities. Their technical domain expertise centers on the intersection of clinical diagnostics, data interoperability, and laboratory automation within federally regulated health environments.